The First Hour Golden Hour Management of a Penetrating Trauma Patient by the Red Crescent
DOI:
https://doi.org/10.22399/ijcesen.4250Keywords:
Golden Hour, penetrating trauma, Red Crescent, emergency response, assessment, stabilizationAbstract
In the realm of emergency medical response, particularly in the context of penetrating trauma, the "Golden Hour" refers to the critical time frame within the first hour following an injury. Red Crescent teams are trained to prioritize rapid assessment, stabilization, and transport of penetrating trauma patients to optimize outcomes. During this crucial period, medical personnel conduct immediate interventions, including airway management, control of hemorrhage, and assessment for life-threatening injuries. The use of tourniquets, pressure dressings, and intravenous fluid resuscitation are essential components of their protocol, aimed at minimizing blood loss and ensuring that vital signs remain stable until definitive care can be provided in a hospital setting. The Red Crescent's approach emphasizes not only medical intervention but also efficient communication and coordination within their teams and with other emergency services. By ensuring that all responders are informed of the trauma patient's status and needs, the Red Crescent can streamline transport and surgical intervention. Additionally, first responders focus on assessing the mechanism of injury, which can provide invaluable insight into potential complications and necessary surgical interventions required upon arrival at the hospital. This comprehensive strategy not only enhances survival rates but also fosters a culture of rapid response and effective trauma management within the Red Crescent teams, ultimately contributing to better outcomes for patients in critical conditions.
References
[1] Alonso M, Brathwaite C, Garcia V et al. Blunt Liver and Spleen Injuries, Non-Operative Management. Chicago: EAST; 2003.
[2] Bickell WH, Wall MJ, Pepe PE et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994; 331: 1105-1109.
[3] Biffl WL, Smith WR, Moore EE et al. Evolution of a multidisciplinary clinical pathway for the management of unstable patients with pelvic fractures. Ann Surg 2001; 233: 843-850.
[4] Blow O, Magliore L, Claridge JA et al. The golden hour and the silver day: detection and correction of occult hypoperfusion within 24 hours improves outcome from major trauma. J Trauma 1999; 47: 964-969.
[5] Borgman MA, Spinella PC, Perkins JG et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805-813.
[6] Brasel KJ, Guse C, Gentilello LM, Nirula R. Heart rate: is it truly a vital sign? J Trauma 2007; 62: 812-817.
[7] Como JJ, Bokhari F, Chiu WC et al. Practice management guidelines for selective nonoperative management of penetrating abdominal trauma. J Trauma 2010; 68: 721-733.
[8] Cotton BA, Au BK, Nunez TC et al. Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications. J Trauma 2009; 66: 41-48.
[9] Doran CM, Doran CA, Woolley T et al. Targeted resuscitation improves coagulation and outcome. J Trauma Acute Care Surg 2012; 72: 835-843.
[10] Duchesne JC, McSwain NE, Cotton BA et al. Damage control resuscitation: the new face of damage control. J Trauma 2010; 69: 976-990.
[11] Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010; 105: 116-121.
[12] Frith D, Goslings JC, Gaarder C et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost 2010; 8: 1919-1925.
[13] Gando S, Sawamura A, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg 2011; 254: 10-19.
[14] General Medical Council. Good Medical Practice. London: GMC; 2009.
[15] Hauser CJ, Boffard K, Dutton R et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010; 69: 489-500.
[16] Hirshberg A, Mattox K. Top Knife. Shrewsbury: tfm; 2004.
[17] Hodgetts TJ, Mahoney PF, Russell MQ, Byers M. ABC to ABC: redefining the military trauma paradigm. Emerg Med J 2006; 23: 745-746.
[18] Hoffman M. The cellular basis of traumatic bleeding. Mil Med 2004; 169(12 Suppl): 5-7.
[19] Holcomb JB, Jenkins D, Rhee P et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma 2007; 62: 307-310.
[20] Jansen JO, Inaba K, Resnick S et al. Selective non-operative management of abdominal gunshot wounds: survey of practice. Injury 2012.
[21] Jansen JO, Thomas R, Loudon MA, Brooks A. Damage control resuscitation for patients with major trauma. BMJ 2009; 338: b1778.
[22] Johansson PI, Ostrowski SR, Secher NH. Management of major blood loss: an update. Acta Anaesthesiol Scand 2010; 54: 1039-1049.
[23] Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009; 17: 45.
[24] Kirkman E, Watts S, Cooper G. Blast injury research models. Philos Trans R Soc Lond B Biol Sci 2011; 366: 144-159.
[25] Lewin J, Maconochie I. Capillary refill time in adults. Emerg Med J 2008; 25: 325-326.
[26] Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008; 65: 951-960.
[27] Lin Y, Stanworth S, Birchall J et al. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2011; 2: CD005011.
[28] Lu YQ, Cai XJ, Gu LH et al. Experimental study of controlled fluid resuscitation in the treatment of severe and uncontrolled hemorrhagic shock. J Trauma 2007; 63: 798-804.
[29] Malone DL, Dunne J, Tracy JK et al. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 2003; 54: 898-905.
[30] Meng ZH, Wolberg AS, Monroe DM, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003; 55: 886-891.
[31] Mitra B, Cameron PA, Parr MJ, Phillips L. Recombinant factor VIIa in trauma patients with the 'triad of death'. Injury 2012; 43: 1409-1414.
[32] Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg 2011; 147: 113-119.
[33] Nascimento B, Lin Y, Callum J et al. Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients. Clinics 2011; 66: 101-106.
[34] National Confidential Enquiry into Patient Outcome and Death. Trauma: Who Cares? London: NCEPOD; 2007.
[35] National Institute for Clinical Excellence. Pre-hospital Initiation of Fluid Replacement Therapy in Trauma. London: NICE; 2004.
[36] Ochsner MG. Factors of failure for nonoperative management of blunt liver and splenic injuries. World J Surg 2001; 25: 1393-1396.
[37] Ordoñez CA, Pino LF, Badiel M et al. Safety of performing a delayed anastomosis during damage control laparotomy in patients with destructive colon injuries. J Trauma 2011; 71: 1512-1517.
[38] Peitzman AB, Harbrecht BG, Rivera L, Heil B. Failure of observation of blunt splenic injury in adults: variability in practice and adverse consequences. J Am Coll Surg 2005; 201: 179-187.
[39] Phelan HA, Gonzalez RP, Patel HD et al. Prestorage leukoreduction ameliorates the effects of aging on banked blood. J Trauma 2010; 69: 330-337.
[40] Revell M, Porter K, Greaves I. Fluid resuscitation in prehospital trauma care: a consensus view. Emerg Med J 2002; 19: 494-498.
[41] Rossaint R, Bouillon B, Cerny V et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14: R52.
[42] Shakur H, Roberts I, Bautista R et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.
[43] Stinger HK, Spinella PC, Perkins JG et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64: S79-S85.
[44] Trauma Audit and Research Network. The Trauma Audit and Research Network: An Overview. Manchester: TARN; 2006.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
